Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2001

01-03-2001

Rapid Decrease of Plasma HCV RNA in Early Phase of Twice Daily Administration of 3 MU Doses Interferon-β in Patients with Genotype 1b Hepatitis C Infection

Authors: Namiki Izumi, Hiromitsu Kumada, Naoaki Hashimoto, Hideharu Harada, Michio Imawari, Mikio Zeniya, Gotaro Toda

Published in: Digestive Diseases and Sciences | Issue 3/2001

Login to get access
Metadata
Title
Rapid Decrease of Plasma HCV RNA in Early Phase of Twice Daily Administration of 3 MU Doses Interferon-β in Patients with Genotype 1b Hepatitis C Infection
Authors
Namiki Izumi
Hiromitsu Kumada
Naoaki Hashimoto
Hideharu Harada
Michio Imawari
Mikio Zeniya
Gotaro Toda
Publication date
01-03-2001
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 3/2001
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/A:1005686829416

Other articles of this Issue 3/2001

Digestive Diseases and Sciences 3/2001 Go to the issue

OriginalPaper

News and Notices

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.